Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies to improve vision in dry AMD.
Many patients continue to live with central vision loss that erodes independence and quality of life.
They may be “stable” anatomically, yet functionally they struggle: recognizing faces, reading mail, managing medications, cooking safely, shopping, paying bills, using a phone or navigating unfamiliar environments. For the clinician, this creates a familiar gap — patients who are doing everything “right” medically but still feel they are